Apheresis
2 clinical trialsnone recruiting1 country
1 substance studiedView
Apheresis
Surgical and medical proceduresVascular disorders
- 1 country
- Substances:Pelacarsen
Diseases
Learn more about your disease – page 34
1 684 diseases in the catalogue8 973 linked trialsUpdated today
Top 10 most studied diseases
Diseases with the highest number of active trials right now.
Colours show each disease's body system – lighter shades rank lower.
- Neoplasms benign, malignant and unspecified58%
- Blood and lymphatic system disorders19%
- Gastrointestinal disorders15%
- Metabolism and nutrition disorders8%
No. 1 most studied
Non-small cell lung cancer
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Respiratory, thoracic and mediastinal disorders
334Active trials · 22% of the top 10
- recruiting now
- 108
- countries
- 27
- open to children
- 0
- substances tested
- 191
Shares are of these ten diseases' active trials together.
All diseases
Browse every disease currently studied across European trials.
A–Z
1 684 diseases
Arrhythmia
2 clinical trials1 recruiting2 countries
- 2 countries
Arrhythmogenic right ventricular dysplasia
2 clinical trials1 recruiting2 countries
2 substances studiedView
1 recruiting
Arrhythmogenic right ventricular dysplasia
Cardiac disordersCongenital, familial and genetic disorders
- 2 countries
- Substances:SacubitrilSpironolactone
Arterial disorder
2 clinical trials1 recruiting9 countries1 open to children
4 substances studiedView
- 9 countries
- Substances:Methylprednisolone HemisuccinateMethylprednisolone Hydrogen Succinate+2 more
Asplenia
2 clinical trials1 recruiting2 countries
8 substances studiedView
- 2 countries
- Substances:LinaclotidePneumococcal polysaccharide serotype 15A conjugated to CRM197+6 more
Asthmatic crisis
2 clinical trialsnone recruiting6 countries
Asthmatic crisis
Respiratory, thoracic and mediastinal disorders
- 6 countries
Astrocytoma malignant
2 clinical trials1 recruiting8 countries
2 substances studiedView
1 recruiting
Astrocytoma malignant
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Nervous system disorders
- 8 countries
- Substances:VorasidenibAminolevulinic Acid Hydrochloride
Autoimmune hepatitis
2 clinical trials1 recruiting12 countries
2 substances studiedView
- 12 countries
- Substances:IanalumabInebilizumab
B-cell unclassifiable lymphoma high grade
2 clinical trials1 recruiting3 countries
14 substances studiedView
1 recruiting
B-cell unclassifiable lymphoma high grade
Blood and lymphatic system disordersNeoplasms benign, malignant and unspecified (incl cysts and polyps)
- 3 countries
- Substances:AcalabrutinibCisplatin+12 more
Basal cell naevus syndrome
2 clinical trials1 recruiting6 countries
1 substance studiedView
- 6 countries
- Substances:Sonidegib
Beta haemolytic streptococcal infection
2 clinical trials2 recruiting3 countries
2 substances studiedView
- 3 countries
- Substances:Benzylpenicillin SodiumClindamycin Phosphate
Biliary tract disorder
2 clinical trialsnone recruiting4 countries
Biliary tract disorder
Hepatobiliary disorders
- 4 countries
Bladder cancer stage II
2 clinical trialsnone recruiting11 countries
Bladder cancer stage II
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Renal and urinary disorders
- 11 countries
Bladder cancer stage III
2 clinical trialsnone recruiting11 countries
Bladder cancer stage III
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Renal and urinary disorders
- 11 countries
Bladder transitional cell carcinoma stage I
2 clinical trials1 recruiting2 countries
1 substance studiedView
1 recruiting
Bladder transitional cell carcinoma stage I
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Renal and urinary disorders
- 2 countries
- Substances:Hexaminolevulinate
Bladder transitional cell carcinoma stage III
2 clinical trialsnone recruiting6 countries
1 substance studiedView
Bladder transitional cell carcinoma stage III
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Renal and urinary disorders
- 6 countries
- Substances:Durvalumab
Bone sarcoma
2 clinical trialsnone recruiting3 countries
2 substances studiedView
Bone sarcoma
Musculoskeletal and connective tissue disordersNeoplasms benign, malignant and unspecified (incl cysts and polyps)
- 3 countries
- Substances:Pyruvic AcidSunitinib
BRAF gene mutation
2 clinical trials1 recruiting7 countries
3 substances studiedView
- 7 countries
- Substances:CobicistatSorafenib+1 more
Breast cancer in situ
2 clinical trialsnone recruiting1 country
4 substances studiedView
Breast cancer in situ
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Reproductive system and breast disorders
Bronchitis
2 clinical trialsnone recruiting2 countries1 open to children
1 substance studiedView
1 open to children
Bronchitis
Infections and infestationsRespiratory, thoracic and mediastinal disorders
- 2 countries
- Substances:LIQUID EXTRACT OF THYME (1:3.45-3.85), EXTRACTION SOLVENT: ETHANOL 27%(V/V)
Bulbospinal muscular atrophy congenital
2 clinical trialsnone recruiting2 countries
3 substances studiedView
Bulbospinal muscular atrophy congenital
Congenital, familial and genetic disordersEndocrine disorders
- 2 countries
- Substances:NIDO-361Nipocalimab+1 more
Caesarean section
2 clinical trials2 recruiting2 countries
3 substances studiedView
- 2 countries
- Substances:Clonidine HydrochlorideMorphine Hydrochloride+1 more
Carcinoid syndrome
2 clinical trialsnone recruiting8 countries
2 substances studiedView
Carcinoid syndrome
Endocrine disordersNeoplasms benign, malignant and unspecified (incl cysts and polyps)
- 8 countries
- Substances:Octreotide AcetatePaltusotine
Carotid arteriosclerosis
2 clinical trials1 recruiting2 countries
1 substance studiedView
- 2 countries
- Substances:Xenon